Carregant...
Cardioprotective interventions for cancer patients receiving anthracyclines
BACKGROUND: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose‐dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotective agents have been studied. OBJECTI...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2011
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457676/ https://ncbi.nlm.nih.gov/pubmed/21678342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003917.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|